ArticleScientific reports2025
Robust resolution improvement of 3D UTE-MR angiogram of normal vasculatures using super-resolution convolutional neural network.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Contrast-enhanced UTE-MRA provides detailed angiographic information but at the cost of prolonged scanning periods, which may impose moving artifacts and affect the promptness of diagnosis and treatment of time-sensitive diseases like stroke. This study aims to increase the resolution of rapidly acquired low-resolution UTE-MRA data to high-resolution using deep learning. A total of 20 and 10 contrast-enhanced 3D UTE-MRA data were collected from healthy control and stroke-bearing Wistar rats, respectively. A newly designed 3D convolutional neural network called ladder-shaped residual dense generator (LSRDG) and other state-of-the-art models (SR-ResNet, MRDG64) were implemented, trained, and validated on healthy control data and tested on stroke data. For healthy control data, significantly improved SSIM, PSNR, and MSE results were achieved using our proposed model, respectively 0.983, 36.80, and 0.00021, compared to 0.964, 34.38, and 0.00037 using SR-ResNet and 0.978, 35.47, and 0.00029 using MRDG64. For stroke data, respective SSIM, PSNR, and MSE scores of 0.963, 34.14, and 0.00041 were achieved using our proposed model compared to 0.953, 32.24, and 0.00061 (SR-ResNet) and 0.957, 32.90, and 0.00054 (MRDG64). Moreover, by combining a well-designed network, suitable loss function, and training with smaller patch sizes, the resolution of contrast-enhanced UTE-MRA was significantly improved from 234
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.